Literature DB >> 2568659

Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.

R Halperin1, J J Guerin, K L Davis.   

Abstract

Some atypical neuroleptics have been shown to exert selective effects on the nigrostriatal or mesolimbic dopamine systems as assessed by behavioral, biochemical and electrophysiological measures. This specificity appears to occur using chronic or acute schedules of drug administration. This study examined the effect of chronic administration of haloperidol, clozapine, sulpiride and metoclopramide on stereotypy and locomotor activity elicited by direct injection of dopamine in to the striatum or nucleus accumbens, respectively. Each rat was pre-treated with a neuroleptic drug or vehicle control for 21 days. Five days after the termination of drug treatment, each rat was injected with 10 micrograms dopamine bilaterally, and stereotypy or locomotor activity was measured. Rats pre-treated with metoclopramide exhibited an enhanced stereotypy response, and rats pre-treated with haloperidol, clozapine or sulpiride exhibited enhanced locomotor activity compared to controls. The extent to which these results demonstrate the selective action of these drugs in sensitizing dopamine systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568659     DOI: 10.1007/BF00451692

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

Review 1.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

2.  Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.

Authors:  A J Pijnenburg; W M Honig; J A Van der Heyden; J M Van Rossum
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

3.  3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.

Authors:  J E Leysen
Journal:  Adv Biochem Psychopharmacol       Date:  1980

4.  Dopaminergic agonists differentially affect open-field activity of rats with A10 lesions.

Authors:  G K Hodge; M G Boyeson; R T Linn
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.

Authors:  A Lautin; D Wazer; M Stanley; J Rotorsen; S Gershon
Journal:  Life Sci       Date:  1980-07-28       Impact factor: 5.037

6.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

7.  Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.

Authors:  S I Deutsch; R Halperin; M Stanley; K L Davis
Journal:  Neurochem Res       Date:  1985-04       Impact factor: 3.996

8.  Studies on the mechanism of action of substituted benzamide drugs.

Authors:  C Köhler; S O Ogren; K Fuxe
Journal:  Acta Psychiatr Scand Suppl       Date:  1984

9.  Regional selectivity of neuroleptic drugs: an argument for site specificity.

Authors:  R L Borison; B I Diamond
Journal:  Brain Res Bull       Date:  1983-08       Impact factor: 4.077

10.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

Authors:  L A Chiodo; B S Bunney
Journal:  J Neurosci       Date:  1983-08       Impact factor: 6.167

View more
  3 in total

Review 1.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.

Authors:  H Y Meltzer; M A Lee; R Ranjan; E A Mason; P A Cola
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.